Added value of histogram analysis of apparent diffusion coefficient maps for differentiating triple-negative breast cancer from other subtypes of breast cancer on standard MRI

References

• Leon-Ferre RA, Polley MY, Liu H, et al. Impact of histopathology, tumor-infiltrating lymphocytes, and adjuvant chemotherapy on prognosis of triple-negative breast cancer. Breast Cancer Res Treat. 2018;167(1):89–99. doi:10.1007/s10549-017-4499-728913760
   PubMed Web of Science ®Google Scholar
• Rapiti E, Pinaud K, Chappuis PO, et al. Opportunities for improving triple-negative breast cancer outcomes: results of a population-based study. Cancer Med. 2017;6(3):526–536. doi:10.1002/cam4.99828211614
   PubMed Web of Science ®Google Scholar
• Klimov S, Rida PC, Aleskandarany MA, et al. Novel immunohistochemistry-based signatures to predict metastatic site of triple-negative breast cancers. Br J Cancer. 2017;117(6):826–834. doi:10.1038/bjc.2017.22428720841
   PubMed Web of Science ®Google Scholar
• Agner SC, Rosen MA, Englander S, et al. Computerized image analysis for identifying triple-negative breast cancers and differentiating them from other molecular subtypes of breast cancer on dynamic contrast-enhanced MR images: a feasibility study. Radiology. 2014;272(1):91–99. doi:10.1148/radiol.1412103124620909
   PubMed Web of Science ®Google Scholar
• Durando M, Gennaro L, Cho GY, et al. Quantitative apparent diffusion coefficient measurement obtained by 3.0 Tesla MRI as a potential noninvasive marker of tumor aggressiveness in breast cancer. Eur J Radiol. 2016;85(9):1651–1658. doi:10.1016/j.ejrad.2016.06.01927501902
   PubMed Web of Science ®Google Scholar
• Mori N, Mugikura S, Takasawa C, et al. Peritumoral apparent diffusion coefficients for prediction of lymphovascular invasion in clinically node-negative invasive breast cancer. Eur Radiol. 2016;26(2):331–339. doi:10.1007/s00330-015-3847-426024846
   PubMed Web of Science ®Google Scholar
• Tan SL, Rahmat K, Rozalli FI, et al. Differentiation between benign and malignant breast lesions using quantitative diffusion-weighted sequence on 3 T MRI. Clin Radiol. 2014;69(1):63–71. doi:10.1016/j.crad.2013.08.00724156797
   PubMed Web of Science ®Google Scholar
• Yoo H, Shin HJ, Baek S, et al. Diagnostic performance of apparent diffusion coefficient and quantitative kinetic parameters for predicting additional malignancy in patients with newly diagnosed breast cancer. Magn Reson Imaging. 2014;32(7):867–874. doi:10.1016/j.mri.2014.04.01224907855
   PubMed Web of Science ®Google Scholar
• Kul S, Cansu A, Alhan E, Dinc H, Gunes G, Reis A. Contribution of diffusion-weighted imaging to dynamic contrast-enhanced MRI in the characterization of breast tumors. Am J Roentgenol. 2011;196(1):210–217. doi:10.2214/AJR.10.425821178069
   PubMed Web of Science ®Google Scholar
• Suo S, Zhang K, Cao M, et al. Characterization of breast masses as benign or malignant at 3.0 T MRI with whole-lesion histogram analysis of the apparent diffusion coefficient. J Magn Reson Imaging. 2016;43(4):894–902. doi:10.1002/jmri.2504326343918
   PubMed Web of Science ®Google Scholar
• Bougias H, Ghiatas A, Priovolos D, Veliou K, Christou A. Whole-lesion apparent diffusion coefficient (ADC) metrics as a marker of breast tumour characterization-comparison between ADC value and ADC entropy. Br J Radiol. 2016;89(1068):20160304. doi:10.1259/bjr.2016030427718592
   PubMed Web of Science ®Google Scholar
• Kim EJ, Kim SH, Park GE, et al. Histogram analysis of apparent diffusion coefficient at 3.0 t: correlation with prognostic factors and subtypes of invasive ductal carcinoma. J Magn Reson Imaging. 2015;42(6):1666–1678. doi:10.1002/jmri.2493425919239
   PubMed Web of Science ®Google Scholar
• Liu HL, Zong M, Wei H, et al. Preoperative predicting malignancy in breast mass-like lesions: value of adding histogram analysis of apparent diffusion coefficient maps to dynamic contrast-enhanced magnetic resonance imaging for improving confidence level. Br J Radiol. 2017;90(1079):20170394. doi:10.1259/bjr.2017039428876982
   PubMed Web of Science ®Google Scholar
• Goldhirsch A, Wood WC, Coates AS, et al. Strategies for subtypes–dealing with the diversity of breast cancer: highlights of the St. Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011. Ann Oncol. 2011;22(8):1736–1747. doi:10.1093/annonc/mdr30421709140
   PubMed Web of Science ®Google Scholar
• Sickles EA, D’Orsi CJ, Bassett LW, et al. ACR BI-RADS mammography In: ACR BI-RADS Atlas, Breast Imaging Reporting and Data System. Reston (VA): American College of Radiology; 2013:141–167.
   Google Scholar
• Carey LA, Perou CM, Livasy CA, et al. Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study. JAMA. 2006;295(21):2492–2502. doi:10.1001/jama.295.21.249216757721
   PubMed Web of Science ®Google Scholar
• Dent R, Trudeau M, Pritchard KI, et al. Triple-negative breast cancer: clinical features and patterns of recurrence. Clin Cancer Res. 2007;13(15 Pt 1):4429–4434. doi:10.1158/1078-0432.CCR-06-304517671126
   PubMed Web of Science ®Google Scholar
• Anders C, Carey LA. Understanding and treating triple-negative breast cancer. Oncology (Williston Park). 2008;22(11):1233–9; discussion 1239–40, 1243.
   PubMed Web of Science ®Google Scholar
• Whitman GJ, Albarracin CT, Gonzalez-Angulo AM. Triple-negative breast cancer: what the radiologist needs to know. Semin Roentgenol. 2011;46(1):26–39. doi:10.1053/j.ro.2010.09.00421134526
   PubMed Web of Science ®Google Scholar
• Sutton EJ, Dashevsky BZ, Oh JH, et al. Breast cancer molecular subtype classifier that incorporates MRI features. J Magn Reson Imaging. 2016;44(1):122–129. doi:10.1002/jmri.2511926756416
   PubMed Web of Science ®Google Scholar
• Sung JS, Stamler S, Brooks J, et al. Breast cancers detected at screening MR imaging and mammography in patients at high risk: method of detection reflects tumor histopathologic results. Radiology. 2016;280(3):716–722. doi:10.1148/radiol.201615141927097237
   PubMed Web of Science ®Google Scholar
• Schrading S, Kuhl CK. Mammographic, US, and MR imaging phenotypes of familial breast cancer. Radiology. 2008;246(1):58–70. doi:10.1148/radiol.246106217318096529
   PubMed Web of Science ®Google Scholar
• Youk JH, Son EJ, Chung J, Kim JA, Kim EK. Triple-negative invasive breast cancer on dynamic contrast-enhanced and diffusion-weighted MR imaging: comparison with other breast cancer subtypes. Eur Radiol. 2012;22(8):1724–1734. doi:10.1007/s00330-012-2425-222527371
   PubMed Web of Science ®Google Scholar
• Sung JS, Jochelson MS, Brennan S, et al. MR imaging features of triple-negative breast cancers. Breast J. 2013;19(6):643–649. doi:10.1111/tbj.1218224015869
   PubMed Web of Science ®Google Scholar
• Uematsu T, Kasami M, Yuen S. Triple-negative breast cancer: correlation between MR imaging and pathologic findings. Radiology. 2009;250(3):638–647. doi:10.1148/radiol.250308105419244039
   PubMed Web of Science ®Google Scholar
• Dogan BE, Gonzalez-Angulo AM, Gilcrease M, Dryden MJ, Yang WT. Multimodality imaging of triple receptor-negative tumors with mammography, ultrasound, and MRI. AJR Am J Roentgenol. 2010;194(4):1160–1166. doi:10.2214/AJR.09.235520308526
   PubMed Web of Science ®Google Scholar
• Schmitz AM, Loo CE, Wesseling J, Pijnappel RM, Gilhuijs KG. Association between rim enhancement of breast cancer on dynamic contrast-enhanced MRI and patient outcome: impact of subtype. Breast Cancer Res Treat. 2014;148(3):541–551. doi:10.1007/s10549-014-3170-925376743
   PubMed Web of Science ®Google Scholar
• Molinari C, Clauser P, Girometti R, et al. MR mammography using diffusion-weighted imaging in evaluating breast cancer: a correlation with proliferation index. Radiol Med. 2015;120(10):911–918. doi:10.1007/s11547-015-0527-z25776017
   PubMed Web of Science ®Google Scholar
• Razek AA, Gaballa G, Denewer A, Nada N. Invasive ductal carcinoma: correlation of apparent diffusion coefficient value with pathological prognostic factors. NMR Biomed. 2010;23(6):619–623. doi:10.1002/nbm.150320232453
   PubMed Web of Science ®Google Scholar
• Park SH, Moon WK, Cho N, et al. Diffusion-weighted MR imaging: pretreatment prediction of response to neoadjuvant chemotherapy in patients with breast cancer. Radiology. 2010;257(1):56–63. doi:10.1148/radiol.1009202120851939
   PubMed Web of Science ®Google Scholar
• Arponen O, Masarwah A, Sutela A, et al. Incidentally detected enhancing lesions found in breast MRI: analysis of apparent diffusion coefficient and T2 signal intensity significantly improves specificity. Eur Radiol. 2016;26(12):4361–4370. doi:10.1007/s00330-016-4326-227114285
   PubMed Web of Science ®Google Scholar